🔓 Unlock the full profile of Jay Short (Bioatla, Inc.), including verified contact details, financial insights, and professional associations.
See Jay Short Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: jay*****@bio******.com
Mobile: 74852*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Jay Short serves as the Chairman, CEO, and Cofounder of BioAtla, Inc., a biotechnology company founded in March 2007 in San Diego, California.
- Under the leadership of Jay Short, BioAtla focuses on developing innovative therapeutic protein products designed to address unmet medical needs in oncology, particularly through its proprietary CAB technology.
- BioAtla went public, trading on the NASDAQ under the symbol BCAB, highlighting the company's growth and attractiveness to investors, with a current market cap of approximately $27.6 million.
- Jay Short has a proven history in leadership roles prior to BioAtla, including a position as Principal at Capia IP starting in January 2005 and serving as Director at LusBio Inc. and Senomyx, Inc. in the respective years.
- Jay Short was previously involved as a Director at Ciris Energy, contributing to advancements in renewable energy solutions and technology development from January 2007 until November 2016.
- BioAtla has experienced fluctuations in headcount growth, with a recent increase of 1.6% over six months, yet a decline of 3.1% over the past year, indicating ongoing challenges in market conditions and recruitment.
- The organization maintains an online presence through its website and social media, promoting advancements in biotherapeutics, and engaging potential investors and customers.
- Jay Short's contributions to the company reflect a strong commitment to fostering scientific innovation and strategic growth in a highly competitive biotechnology landscape.